(Total Views: 544)
Posted On: 03/05/2021 7:06:16 PM
Post# of 153963
Correct:
Given the size of this critically ill population relative to the trial’s size (62 out of 384 patients), the Company has concurrently filed an additional protocol with the FDA using the existing sites from its CD12 trial to quickly enroll patients in this population during the pendency of these ongoing regulatory discussions.
Emphasize "on going", "filed an additional protocol", I think this is to take out it to 60 days.
Interesting this was released after yesterday's dog and pony show on local TV.
No need for an additional protocol if EUA is forthcoming. IMO
Given the size of this critically ill population relative to the trial’s size (62 out of 384 patients), the Company has concurrently filed an additional protocol with the FDA using the existing sites from its CD12 trial to quickly enroll patients in this population during the pendency of these ongoing regulatory discussions.
Emphasize "on going", "filed an additional protocol", I think this is to take out it to 60 days.
Interesting this was released after yesterday's dog and pony show on local TV.
No need for an additional protocol if EUA is forthcoming. IMO
(2)
(0)
